Each capsule contains 1 mg of the active compound, with the standard regimen being one capsule taken three times per day
Under section 503B(b) of the FDCA, a compounder can register as an outsourcing facility with FDA
It triggers the release of growth hormone without significantly impacting other hormones such as cortisol or prolactin, which minimizes side effects
A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1